CRT 2017: Advanced Use of Percutaneous Support Devices in Protected PCI and CGS

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

Advanced Use of Percutaneous Support Devices in Protected PCI and CGS

Featuring

  • John M. Lasala
  • Tony DeMartini
  • Elias Haddad
  • Raj Tayal
  • Adam Greenbaum
  • Perwaiz Meraj
  • Daniel Burkhoff
  • Navin Kapur
  • Ted Schreiber
  • Lynn Morris
  • Seth Bilazarian

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Complete Revascularization Versus Staged Procedures - John M. Lasala
CTO Supported PCI - Tony DeMartini
MVD with Moderately Reduced EF - Elias Haddad
Axillary Insertion of Impella - Raj Tayal
Alternate Access - Adam Greenbaum
Heart Team Approach; Protocols and Algorithms; and Outreach Programs - Perwaiz Meraj
Management of Shock - What is Happening "Under the Hood" When Treating Patients With Pressors, IABP, Impella and ECMO - Daniel Burkhoff
Choosing MCS Options in AMI Cardiogenic Shock: Rationale for Impella First - Navin Kapur
Door-To-Unloading: A New Quality Metric - Navin Kapur
Practical Insights for Adding Hemodynamic Support Into Your Critical Care Path: The Detroit Cardiogenic Shock Initiative (CSI) Experience - Ted Schreiber
Should Every MCS Patient Have a RHC? - Daniel Burkhoff
Percutaneous Support Prior to PCI (A Case From Detroit CSI) - Ted Schreiber
Right and Left Ventricular Support - Lynn Morris
Closing Remarks - Seth Bilazarian

Target Audience

  • Cardiologists
  • Interventional Cardiologists
  • Interventional Fellows
  • Interventional Radiologists
  • Vascular Surgeons
  • Emergency Physicians
  • Physicians with an interest in Cardiovascular Innovations

Learning Objectives

Related Moments

CRT 2015 Technology & Innovation - Hypertension Definition, Pathophysiology, and Medical Therapy
Conference
A session on Hypertension Definition, Pathophysiology, and Medical Therapy at CRT 2015
TAVI: Why Are We Conducting Randomised Trials In Intermediate Risk Patients?
Webinar
Webinar - TAVI: Why Are We Conducting Randomised Trials In Intermediate Risk Patients?
Percutaneous Closure Of Patent Foramen Ovale – Data From Randomized Clinical Trials And Meta-Analyses
Journal
Article on Percutaneous Closure Of Patent Foramen Ovale – Data From Randomized Clinical Trials And Meta-Analyses
Loading Simple Education